Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F24%3A00080219" target="_blank" >RIV/65269705:_____/24:00080219 - isvavai.cz</a>

Výsledek na webu

<a href="https://ashpublications.org/blood/article/143/19/1891/514792/Diagnosis-prognostic-factors-and-assessment-of-ALL" target="_blank" >https://ashpublications.org/blood/article/143/19/1891/514792/Diagnosis-prognostic-factors-and-assessment-of-ALL</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1182/blood.2023020794" target="_blank" >10.1182/blood.2023020794</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel

Popis výsledku v původním jazyce

Working groups of the European LeukemiaNet have published several important consensus guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological subgroups and the knowledge on disease biology and therapeutic options is increasing exponentially. The European Working Group for Adult ALL has therefore summarized the current state of the art and provided comprehensive consensus recommendations for diagnostic approaches, biologic and clinical characterization, prognostic factors, and risk strati fi cation as well as de fi nitions of endpoints and outcomes. Aspects of treatment, management of subgroups and speci fi c situations, aftercare, and supportive care are covered in a separate publication. The present recommendation intends to provide guidance for the initial management of adult patients with ALL and to de fi ne principles as a basis for future collaborative research.

Název v anglickém jazyce

Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel

Popis výsledku anglicky

Working groups of the European LeukemiaNet have published several important consensus guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological subgroups and the knowledge on disease biology and therapeutic options is increasing exponentially. The European Working Group for Adult ALL has therefore summarized the current state of the art and provided comprehensive consensus recommendations for diagnostic approaches, biologic and clinical characterization, prognostic factors, and risk strati fi cation as well as de fi nitions of endpoints and outcomes. Aspects of treatment, management of subgroups and speci fi c situations, aftercare, and supportive care are covered in a separate publication. The present recommendation intends to provide guidance for the initial management of adult patients with ALL and to de fi ne principles as a basis for future collaborative research.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30205 - Hematology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Blood

ISSN

0006-4971

e-ISSN

1528-0020

Svazek periodika

143

Číslo periodika v rámci svazku

19

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

12

Strana od-do

1891-1902

Kód UT WoS článku

001239871000001

EID výsledku v databázi Scopus

—